Evidence map›Paper›PMID 15566434›Full record

ArticleInternational journal of experimental pathology2004

Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.

Kalembeyi Ilunga, Rika Nishiura, Hiroyasu Inada, Amro El-Karef, Kyoko Imanaka-Yoshida, Teruyo Sakakura, Toshimichi Yoshida

Open access · greenAbstract read
In one paragraph

Article in International journal of experimental pathology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Matricellular proteins produced by melanocytes and melanomas: in search for functions.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2008
    Article
  12. Review
  13. Article
  14. Article
  15. The functional role of reactive stroma in benign prostatic hyperplasia.Differentiation; research in biological diversity
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Kalembeyi IlungaDepartment of Pathology, Mie University School of Medicine, Mie, Japan.
Rika Nishiura
Hiroyasu Inada
Amro El-Karef
Kyoko Imanaka-Yoshida
Teruyo Sakakura
Toshimichi Yoshida
Mie University · JPUniversity of Lubumbashi · CD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor-beta (TGF-beta), tenascin-C (TN-C) and matrix metalloproteinases (MMPs) have been demonstrated independently to be associated with disease progression and poor prognosis in patients with breast cancer. The present study explored effects of TGF-beta and TN-C on MMP-9 expression and cancer invasion. An experimental study was designed to analyse MDA-MB-231 breast cancer cells, known for their high invasiveness, after stimulation with TGF-beta1 and/or TN-C. TGF-beta1 stimulated TN-C expression in the cells. Co-stimulation of MDA-MB-231 cells with TN-C and TGF-beta increased MMP-9 expression at both the gene (28-fold) and the protein levels. The in vitro invasion also increased (4-fold). GM6001 inhibited the invasion induced by the co-stimulation. The combined effect of TN-C and TGF-beta resulted in enhanced MMP-9 expression and cancer invasion in vitro.

Indexed as

Breast NeoplasmsCarcinogensCell Line, TumorFemaleHumansMatrix Metalloproteinase 9Neoplasm InvasivenessNeoplasm ProteinsReverse Transcriptase Polymerase Chain ReactionTenascinTransforming Growth Factor betaUp-RegulationCarcinogensMatrix Metalloproteinase 9Neoplasm ProteinsTenascinTransforming Growth Factor beta

Identifiers

PMID15566434
PMCPMC2517534
OpenAlexW1600765527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.